Role of ST6GAL1 in Thyroid Cancers: Insights from Tissue Analysis and Genomic Datasets.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
15 Nov 2023
Historique:
received: 13 10 2023
revised: 10 11 2023
accepted: 13 11 2023
medline: 27 11 2023
pubmed: 25 11 2023
entrez: 25 11 2023
Statut: epublish

Résumé

Thyroid cancer is the predominant endocrine-related malignancy. ST6 β-galactoside α2,6-sialyltransferase 1 (ST6GAL1) has been studied in various types of cancers; however, the expression and function of ST6GAL1 in thyroid cancer has not been investigated so far. Previously, we conducted two genome-wide association studies and have identified the association of the

Identifiants

pubmed: 38003522
pii: ijms242216334
doi: 10.3390/ijms242216334
pmc: PMC10671354
pii:
doi:

Substances chimiques

RNA, Messenger 0
ST6GAL1 protein, human EC 2.4.99.1
beta-D-Galactoside alpha 2-6-Sialyltransferase EC 2.4.99.1
Antigens, CD 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Croatian Science Foundation
ID : 2593

Références

Mol Ther Oncolytics. 2020 Jan 10;16:124-133
pubmed: 32055676
Endokrynol Pol. 2019;70(5):423-429
pubmed: 31681970
Cancers (Basel). 2021 Mar 07;13(5):
pubmed: 33799953
Mol Pharmacol. 2005 Oct;68(4):1106-13
pubmed: 16014806
Int J Mol Sci. 2022 Feb 16;23(4):
pubmed: 35216288
BMC Cancer. 2014 Dec 02;14:901
pubmed: 25465919
Oncology. 2003;65(2):139-45
pubmed: 12931020
Nat Genet. 2012 Jan 22;44(3):319-22
pubmed: 22267200
J Biol Chem. 2014 Dec 12;289(50):34627-41
pubmed: 25344606
Cancer Res. 2016 Jul 1;76(13):3978-88
pubmed: 27216178
Endokrynol Pol. 2019;70(1):86-100
pubmed: 30843179
Glycobiology. 2018 Nov 1;28(11):898-903
pubmed: 30016515
Thyroid. 2019 Jun;29(6):886-893
pubmed: 30929638
Cell. 2014 Oct 23;159(3):676-90
pubmed: 25417114
Thyroid. 2005 Jul;15(7):645-52
pubmed: 16053379
J Biol Chem. 1999 Aug 27;274(35):25099-107
pubmed: 10455190
Gynecol Oncol. 2003 Jun;89(3):395-401
pubmed: 12798701
PLoS One. 2011;6(7):e22280
pubmed: 21814573
Oncotarget. 2017 Jan 31;8(5):7691-7709
pubmed: 28032597
Oncol Rep. 2016 Apr;35(4):2131-40
pubmed: 26820593
Nat Commun. 2017 Feb 14;8:14517
pubmed: 28195142
Int J Cancer. 2002 May 10;99(2):260-6
pubmed: 11979442
Gynecol Oncol. 2005 Dec;99(3):631-9
pubmed: 16112178
Int J Cancer. 2015 Oct 15;137(8):1870-8
pubmed: 25855579
J Clin Endocrinol Metab. 2018 Dec 1;103(12):4384-4394
pubmed: 30099483
Thyroid. 2014 Apr;24(4):625-38
pubmed: 24251883
Acta Clin Croat. 2018 Sep;57(3):518-527
pubmed: 31168186
J Clin Endocrinol Metab. 2013 Oct;98(10):E1674-81
pubmed: 23894154
Cancer Res. 2003 Apr 1;63(7):1454-7
pubmed: 12670889
Oncotarget. 2017 Apr 25;8(17):28028-28041
pubmed: 28427206
N Engl J Med. 2016 Sep 15;375(11):1054-67
pubmed: 27626519
Proc Natl Acad Sci U S A. 2020 Mar 17;117(11):5997-6002
pubmed: 32132206
Biochem Biophys Res Commun. 2012 Apr 13;420(3):611-5
pubmed: 22445893
Nat Commun. 2017 Jul 13;8:15966
pubmed: 28703219
Cancer Res. 2001 Sep 15;61(18):6822-9
pubmed: 11559557
Nat Genet. 2009 Apr;41(4):460-4
pubmed: 19198613
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
Br J Cancer. 2021 Jan;124(1):76-90
pubmed: 33144696
Glycoconj J. 2017 Apr;34(2):147-156
pubmed: 27975160
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
Oncotarget. 2016 Oct 4;7(40):65374-65388
pubmed: 27588482
Front Oncol. 2018 Mar 13;8:68
pubmed: 29594046
Glycobiology. 2021 Jun 3;31(5):530-539
pubmed: 33320246
Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8251-6
pubmed: 9653173
Nat Rev Endocrinol. 2019 Jun;15(6):323-338
pubmed: 30886364
Lancet. 2016 Dec 3;388(10061):2783-2795
pubmed: 27240885
JAMA Netw Open. 2020 Jun 1;3(6):e208759
pubmed: 32589231
J Biol Chem. 2011 Jul 1;286(26):22982-90
pubmed: 21550977
Thyroid. 2019 Apr;29(4):530-539
pubmed: 30654714
EMBO J. 1989 Sep;8(9):2537-42
pubmed: 2583123
Nat Commun. 2020 Aug 7;11(1):3981
pubmed: 32769997

Auteurs

Ivana Gunjača (I)

Department of Medical Biology, School of Medicine, University of Split, 21000 Split, Croatia.

Benjamin Benzon (B)

Department of Anatomy, Histology and Embryology, School of Medicine, University of Split, 21000 Split, Croatia.

Nikolina Pleić (N)

Department of Medical Biology, School of Medicine, University of Split, 21000 Split, Croatia.

Mirjana Babić Leko (M)

Department of Medical Biology, School of Medicine, University of Split, 21000 Split, Croatia.

Valdi Pešutić Pisac (V)

Clinical Department of Pathology, Forensic Medicine and Cytology, University Hospital of Split, 21000 Split, Croatia.

Ana Barić (A)

Department of Nuclear Medicine, University Hospital of Split, 21000 Split, Croatia.

Dean Kaličanin (D)

Department of Medical Biology, School of Medicine, University of Split, 21000 Split, Croatia.

Ante Punda (A)

Department of Nuclear Medicine, University Hospital of Split, 21000 Split, Croatia.

Ozren Polašek (O)

Department of Public Health, School of Medicine, University of Split, 21000 Split, Croatia.

Katarina Vukojević (K)

Department of Anatomy, Histology and Embryology, School of Medicine, University of Split, 21000 Split, Croatia.

Tatijana Zemunik (T)

Department of Medical Biology, School of Medicine, University of Split, 21000 Split, Croatia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH